Log In
Print this Print this

Azedra (Ultratrace I-131-MIBG, Ultratrace iobenguane I 131)

  Manage Alerts
Collapse Summary General Information
Company Progenics Pharmaceuticals Inc.
DescriptionRadiolabeled norepinephrine analog
Molecular Target Norepinephrine transporter
Mechanism of ActionRadiolabelled protein
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationNeuroendocrine tumors
Indication DetailsTreat malignant relapsed/refractory pheochromocytoma; Treat neuroendocrine tumors; Treat pheochromocytoma; Treat refractory high-risk neuroblastoma
Regulatory Designation

U.S. - Fast Track (Treat neuroendocrine tumors);
U.S. - Orphan Drug (Treat neuroendocrine tumors);
U.S. - Special Protocol Assessment (Treat malignant relapsed/refractory pheochromocytoma)


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today